Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ad Watchdog Warns Against Quincy Bioscience Memory Drug
January 20, 2016.
Consumer advocacy organization truthinadvertising.org (TINA.org) has alerted ABC, NBC, Turner Broadcasting, Fox Broadcasting, and The Weather Channel, to the airing of "deceptive ads for Prevagen", marketed by Quincy Bioscience as a "brain supplement" purported to improve memory in 90 days.
The ads for Prevagen have aired thousands of times; Quincy Bioscience has sold over two million bottles since the product's launch in 2007. A TINA.org investigation reports however that the company "does not have the required scientific evidence to support its improved memory claims" and that they "constitute clear violations of each network's advertising guidelines".
Recent Videos
Related Content
